TORISEL 25 MG/ML IV FLC

Torisel (temsirolimus) is a medication used in the treatment of advanced renal cell carcinoma (kidney cancer) and mantle cell lymphoma. The formulation you mentioned, Torisel 25 mg/mL IV FLC, indicates that it is a solution for intravenous infusion contained in a vial (flask). The concentration of temsirolimus in the solution is 25 mg per milliliter (mg/mL). Temsirolimus belongs to a class of medications called mammalian target of rapamycin (mTOR) inhibitors. It works by inhibiting mTOR, a protein kinase that regulates cell growth, proliferation, and survival. By inhibiting mTOR, temsirolimus helps to slow down or stop the growth of cancer cells. The specific dosage and administration regimen of Torisel depend on factors such as the type and stage of cancer being treated, the patient’s overall health, and other medications they may be taking. It’s crucial to receive Torisel under the supervision of a healthcare professional experienced in the use of chemotherapy drugs and to follow their instructions carefully to ensure optimal treatment outcomes and minimize potential side effects.